Safety of High-dose Tirofiban During Coronary Angioplasty

NCT00566891 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 2000

Last updated 2011-02-02

No results posted yet for this study

Summary

This single-centre study is intended to retrospectively check the safety of high-dose bolus of tirofiban in patients who underwent percutaneous angioplasty.

Conditions

Interventions

DRUG

tirofiban

tirofiban high dose bolus 25µ/Kg

DRUG

Clopidogrel

Sponsors & Collaborators

  • S. Anna Hospital

    lead OTHER

Principal Investigators

  • Michele Schiariti, MD · University of Roma La Sapienza

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2008-07-31
Completion
2009-02-28

Countries

  • Italy

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00566891 on ClinicalTrials.gov